4 May 2026

Cardiovascular Diabetes Obesity Research

A potential new way to target excess glycogen stores

25 April 2026

Diabetes Pharmaceuticals

PBAC says yes to tirzepatide for T2D – but Lilly says no

10 April 2026

Clinical Diabetes Research

Diabetes referrals lost in the fog says new study

2 April 2026

Clinical Diabetes Pharmaceuticals

An update on semaglutide for CKD in the presence of T2D

10 March 2026

Clinical Diabetes Renal

Coming up: the role of GLP-1 in the management of CKD in T2D

27 February 2026

Diabetes Pharmaceuticals TGA

Two oral GLP-1 RAs go head-to-head

26 February 2026

Diabetes Endocrinology Haematology

Metabolic blockbusters enter the bloodstream

6 February 2026

Clinical Diabetes Physiotherapy Renal

CKD in diabetes: What clinicians need to check early

2 February 2026

Clinical Diabetes Renal

From screening to action: practical CKD tips

8 December 2025

Diabetes Pharmaceuticals Weight management

Oral GLP1 hits big numbers in global trial

4 November 2025

Diabetes Obesity Pharmaceuticals

UK regulators smash illegal weight-loss drug factory

23 October 2025

Diabetes Pharmaceuticals TGA

Oral GLP-1 set for TGA submission

22 October 2025

Clinical Diabetes Renal

Coming up: Panel discussion on GLP1s for CKD in T2D

16 October 2025

Diabetes Obesity

GLP-1 RAs linked to rising rates of hair loss

6 October 2025

Diabetes Pregnancy Women

High folate linked to gestational diabetes

24 September 2025

Cardiology Clinical Diabetes

Coming up: cardiovascular outcomes & GLP1s – an update